Rebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins

The suppressor of T cell receptor signaling (Sts) proteins are negative regulators of immune signaling. Genetic inactivation of these proteins leads to significant resistance to infection. From a 590,000 compound high-throughput screen, we identified the 2-(1H)-quinolinone derivative, rebamipide, as a putative inhibitor of Sts phosphatase activity. Rebamipide, and a small library of derivatives, are competitive, selective inhibitors of Sts-1 with IC50 values from low to submicromolar. SAR analysis indicates that the quinolinone, the acid, and the amide moieties are all essential for activity. A crystal structure confirmed the SAR and reveals key interactions between this class of compound and the protein. Although rebamipide has poor cell permeability, we demonstrated that a liposomal preparation can inactivate the phosphatase activity of Sts-1 in cells. These studies demonstrate that Sts-1 enzyme activity can be pharmacologically inactivated and provide foundational tools and insights for the development of immune-enhancing therapies that target the Sts proteins.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:67

Enthalten in:

Journal of medicinal chemistry - 67(2024), 3 vom: 08. Feb., Seite 1949-1960

Sprache:

Englisch

Beteiligte Personen:

Aziz, Faisal [VerfasserIn]
Reddy, Kanamata [VerfasserIn]
Fernandez Vega, Virneliz [VerfasserIn]
Dey, Raja [VerfasserIn]
Hicks, Katherine A [VerfasserIn]
Rao, Sumitha [VerfasserIn]
Jordan, Luis Ortiz [VerfasserIn]
Smith, Emery [VerfasserIn]
Shumate, Justin [VerfasserIn]
Scampavia, Louis [VerfasserIn]
Carpino, Nicholas [VerfasserIn]
Spicer, Timothy P [VerfasserIn]
French, Jarrod B [VerfasserIn]

Links:

Volltext

Themen:

4QD397987E
Alanine
EC 3.1.3.2
Enzyme Inhibitors
Histidine
Journal Article
LR583V32ZR
OF5P57N2ZX
Phosphoric Monoester Hydrolases
Quinolones
Rebamipide
Receptors, Antigen, T-Cell

Anmerkungen:

Date Completed 09.02.2024

Date Revised 25.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.jmedchem.3c01763

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM36743122X